Sandu Pharmaceuticals Share Price

Sandu Pharmaceuticals

CMP as on24-May-22 15:29

₹ 75.70
2.25 3.06%

Open

₹ 75.00

Turnover (lac)

₹ 1

Prev. Close

₹ 73.45

Day's Vol (shares)

₹ 4,143

Day's Range

₹ 72.50
₹ 77.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 05-Feb-2022 - -
SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve 1.Approval of Unaudited Financial Results for the Q ended 31st December 2021. 2.Appointment of Chairman of the Company 3.Any other matter 1. Appointment of Shri K Vinay Kumar, Independent Director(DIN: 02322747) as Chairman of the Company. 2. Approved Un-audited Financial Results for the Quarter ended 31st December 2021. 3. Approved and took decision on conversion of the 02nd Tranch of 8,89,667 nos of Equity warrants into Equity Shares at Rs 20.69 per Shares as per the sanction given by BSE dated 26th March 2021 asking the allottees to bring 02nd Tranche subscription money. 4. Consider and Approved incorporating a wholly owned Subsidiary Company of Sandu Pharmaceuticals Limited. Unaudited Financial Results for Q ended 31st December 2021 (As per BSE Announcement Dated on 14/02/2022)
Board Meeting - 25-Nov-2021 - -
Inter alia, to consider and approve Appointment of Internal Auditor for Mumbai at its Corporate Office Outcome of the Board Meeting dated 29.11.2021 (As Per BSE Announcement dated on 29.11.2021)
Board Meeting - 01-Nov-2021 - -
Quarterly Results SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2021 ,inter alia, to consider and approve 1. approval of Unaudited Financial Results for Q ended 30th September 2021. 2.Any other matter with permission of chairman (As per BSE Announcement Dated on 30/10/2021) Outcome of the Board Meeting dated 13.11.2021 (As Per BSE Announcement dated on 13.11.2021)
Board Meeting - 03-Aug-2021 - -
SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 ,inter alia, to consider and approve 1. Approval for Unaudited Financials results for Q ended 30th June 2021. 2.To consider Recommend Dividend for the Financial year 2020-21 Board to consider/recommend Dividend for the Financial Year ended 2020-21. Corporate Action Board Approves Dividend Outcome of the Board Meeting dated 14th August 2021 (As Per BSE Announcement Dated on 14.08.2021)
Board Meeting - 19-Jun-2021 - -
SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve Approval of Audited Financial Results for the Quarter and Year ended 31st March 2021. Outcome of the Board Meeting dated 30.06.2021 Audited Financials Results for the quarter and year ended 31st March 2021. (As Per BSE Announcement dated on 30.06.2021)
Board Meeting - 02-Jun-2021 - -
SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2021 ,inter alia, to consider and approve Meeting of the Board of Directors of the Company will be held on Thursday, the 10th day of June, 2021 at 5.00 p.m. at the Corporate Office of the Company at Sandu Pharmaceuticals Limited, Sandu Nagar, D K Sandu Marg, Chembur, Mumbai 400 071 to consider the following 1. To consider and take note of the said demise of Shri Bhaskar G Sandu (DIN:02816792), Chairman of our company. 2. To consider and recommend appointment of Statutory Auditor 3. Any other matter with the permission of Chairman. Outcome of the Board Meeting dated 10.06.2021 (As Per BSE Announcement dated on 10.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity